These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 25332

  • 1. Determination of serum nadolol levels by GLC--selected ion monitoring mass spectrometry: comparison with a spectrofluorometric method.
    Funke PT, Malley MF, Ivashkiv E, Cohen AI.
    J Pharm Sci; 1978 May; 67(5):653-7. PubMed ID: 25332
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nadolol binding to human serum proteins.
    Patel L, Johnson A, Turner P.
    J Pharm Pharmacol; 1984 Jun; 36(6):414-5. PubMed ID: 6146679
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. GLC determination of atenolol and beta-blocking agents in biological fluids.
    Wan SH, Maronde RF, Matin SB.
    J Pharm Sci; 1978 Sep; 67(9):1340-2. PubMed ID: 29118
    [Abstract] [Full Text] [Related]

  • 8. Gas chromatographic-mass spectrometric assay for the ultra-short-acting beta-blocker esmolol.
    Sum CY, Yacobi A.
    J Pharm Sci; 1984 Aug; 73(8):1177-9. PubMed ID: 6149299
    [Abstract] [Full Text] [Related]

  • 9. Capillary column GLC-mass spectrometric assay with selected-ion monitoring for timolol and [13C3]timolol in human plasma.
    Carlin JR, Walker RW, Davies RO, Ferguson RT, Vandenheuvel WJ.
    J Pharm Sci; 1980 Oct; 69(10):1111-5. PubMed ID: 7420275
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of kinetic interactions of nadolol and propranolol with cimetidine.
    Duchin KL, Stern MA, Willard DA, McKinstry DN.
    Am Heart J; 1984 Oct; 108(4 Pt 2):1084-6. PubMed ID: 6148867
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sensitive gas chromatographic method for the determination in blood and urine of SL 75212 [4-(2-cyclopropylmethoxyethyl)-1-phenoxy-3-isopropylaminopropan-2-ol], a new beta 1 adrenoceptor blocking agent.
    Bianchetti G, Ganansia J, Morselli PL.
    J Chromatogr; 1979 Aug 01; 176(1):134-9. PubMed ID: 44712
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Liquid-chromatographic determination of nadolol in plasma.
    Gupta RN, Haynes RB, Logan AG, Macdonald LA, Pickersgill R, Achber C.
    Clin Chem; 1983 Jun 01; 29(6):1085-7. PubMed ID: 6851099
    [Abstract] [Full Text] [Related]

  • 16. Determination by coupled high-performance liquid chromatography-gas chromatography of the beta-blocker levomoprolol in plasma following ophthalmic administration.
    Gianesello V, Brenn E, Figini G, Gazzaniga A.
    J Chromatogr; 1989 Jul 07; 473(2):343-52. PubMed ID: 2570078
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Simultaneous determination of befunolol, a beta-blocking agent, and its metabolite in human plasma by gas chromatography with electron-caputre detection.
    Kawahara K, Ofuji T.
    J Chromatogr; 1979 Jan 11; 168(1):266-72. PubMed ID: 33199
    [No Abstract] [Full Text] [Related]

  • 19. Elimination of nadolol by patients with renal impairment.
    Herrera J, Vukovich RA, Griffith DL.
    Br J Clin Pharmacol; 1979 Jan 11; 7 Suppl 2(Suppl 2):227S-231S. PubMed ID: 37878
    [Abstract] [Full Text] [Related]

  • 20. Nadolol in hypertensive patients maintained on long-term hemodialysis.
    Michaels RS, Duchin KL, Akbar S, Meister J, Levin NW.
    Am Heart J; 1984 Oct 11; 108(4 Pt 2):1091-4. PubMed ID: 6148869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.